Efferent therapy in the first-line drug treatment of metastatic colorectal cancer
作者： Z. S. Kotova , T. Yu. Semiglazova , I. A. Baldueva , D. H. Latipova , D. O. Yurlov
DOI: 10.21518/2079-701X-2018-10-172-175
关键词:
摘要:
med-sovet.pro参考文章(15)
Yeowon A. Kim, Steven R. Sloan, Pediatric Therapeutic Apheresis: Rationale and Indications for Plasmapheresis, Cytapheresis, Extracorporeal Photopheresis, and LDL Apheresis Pediatric Clinics of North America. ,vol. 60, pp. 1569- 1580 ,(2013) , 10.1016/J.PCL.2013.08.006
Nevedomskaya Nn, Ahaeva Zy, Abramovskii Sv, Semiglazova Ty, Semenov Ai, Komarov Yi, Kotova Zs, Novik Av, Protsenko Sa, Latipova Dh, Efferent therapy in the treatment of solid tumors Voprosy onkologii. ,vol. 61, pp. 174- ,(2015)
Motaz Qadan, Michael I. D’Angelica, Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease Current Colorectal Cancer Reports. ,vol. 11, pp. 369- 377 ,(2015) , 10.1007/S11888-015-0290-5
Bernd G. Stegmayr, A survey of blood purification techniques. Transfusion and Apheresis Science. ,vol. 32, pp. 209- 220 ,(2005) , 10.1016/J.TRANSCI.2004.10.023
James J Lee, Edward Chu, None, Sequencing of antiangiogenic agents in the treatment of metastatic colorectal cancer. Clinical Colorectal Cancer. ,vol. 13, pp. 135- 144 ,(2014) , 10.1016/J.CLCC.2014.02.001
Fairooz Kabbinavar, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing, Emily Bergsland, Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 21, pp. 60- 65 ,(2003) , 10.1200/JCO.2003.10.066
Feihu Zhou, Zhiyong Peng, Raghavan Murugan, John A. Kellum, Blood purification and mortality in sepsis: a meta-analysis of randomized trials Critical Care Medicine. ,vol. 41, pp. 2209- 2220 ,(2013) , 10.1097/CCM.0B013E31828CF412
Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, Peter J. O'Dwyer, Edith P. Mitchell, Steven R. Alberts, Michael A. Schwartz, Al B. Benson, Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Journal of Clinical Oncology. ,vol. 25, pp. 1539- 1544 ,(2007) , 10.1200/JCO.2006.09.6305
Jolien Tol, Miriam Koopman, Annemieke Cats, Cees J. Rodenburg, Geert J.M. Creemers, Jolanda G. Schrama, Frans L.G. Erdkamp, Allert H. Vos, Cees J. van Groeningen, Harm A.M. Sinnige, Dirk J. Richel, Emile E. Voest, Jeroen R. Dijkstra, Marianne E. Vink-Börger, Ninja F. Antonini, Linda Mol, Johan H.J.M. van Krieken, Otilia Dalesio, Cornelis J.A. Punt, Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer The New England Journal of Medicine. ,vol. 360, pp. 563- 572 ,(2009) , 10.1056/NEJMOA0808268
Kristen K. Ciombor, Richard M. Goldberg, Update on Anti-angiogenesis Therapy in Colorectal Cancer Current Colorectal Cancer Reports. ,vol. 11, pp. 378- 387 ,(2015) , 10.1007/S11888-015-0292-3